Bortezomib
NDC 83090-008, Bortezomib, injection, powder, lyophilized, for solution, from Sintetica US LLC.
- Product NDC
- 83090-008
- Status
- Listed
- Labeler
- Sintetica US LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209622
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83090-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/3.5mL
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83090-008-01 | 83090000801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-008-01) / 3.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d79a71ec-b46d-4961-ad05-8980915cba94
Use it
Look up 83090-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83090-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83090-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.